Showing results (1391-1400 of 2,739) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|July 7, 2010
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivativesTalitha I Verhoef, William K Redekop, Josep Darba, et al.Pharmacogenomics|November 5, 2010
Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipientsPing Wang, Yong Mao, Juan Razo, et al.Pharmacogenomics|September 24, 2010
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovativeThomas Dandekar, Gudrun DandekarPharmacogenomics|February 22, 2011
Institutional Profile: University of California San Diego Pharmacogenomics Education Program (PharmGenEd™): bridging the gap between science and practiceGrace M Kuo, Joseph D Ma, Kelly C Lee, et al.Pharmacogenomics|February 22, 2011
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarkerAyelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, et al.Pharmacogenomics|February 22, 2011
5-Fluorouracil pharmacogenomics: still rocking after all these years?Mario Scartozzi, Elena Maccaroni, Riccardo Giampieri, et al.Pharmacogenomics|February 22, 2011
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine responseRudi Hwang, Renan P Souza, Arun K Tiwari, et al.Pharmacogenomics|April 1, 2011
Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsyPatrick Kwan, Virginia Wong, Ping Wing Ng, et al.Pharmacogenomics|April 1, 2011
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sampleNader Perroud, Guido Bondolfi, Rudolf Uher, et al.Pharmacogenomics|March 24, 2021
Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patientsMohitosh BiswasPageof 274